About us


Founded in 2013 by Christian Girard, a biopharma and consulting veteran, Orphan Drugs Industry Advisory & Intelligence is a boutique strategic consulting practice and intelligence provider, with a unique focus: the rare diseases arena.

  • Strategic Consulting

We assist early-stage biotech companies as well as leading biopharmas executives in operations, deal-making, fund-raising, and mergers & acquisitions. From recommendation to execution.

  • Competitive Intelligence

Our intelligence resources consists in three independent, subscription-based, information platforms focusing respectively on genetic and rare diseases, orphan oncology, and deals (M&A, licensing, and funding rounds):

Feel free to contact us for more information or to request an online demo.